Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.
An estimated 5.3 million people in the U.S. suffer from Alzheimer’s disease (AD). The five current FDA-approved AD medications only help mask the disease symptoms instead of treating the underlying ...
Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.
The use of short intravenous pulses of methylprednisolone followed by reduced-dose oral prednisone is associated with a ...
The March, 2026, decision by the French drug regulatory agency to approve intravenous racemic ketamine for the treatment of adult severe suicidal crisis1 represents a major step forward in the ...
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-four (54%) disapprove. The latest figures ...
Many studies require intravenous (i.v.) delivery of drugs, depletion agents or other therapeutic agents. In mice, the lateral tail vein is the most common route of administration. Many researchers, ...
Sepsis is a rare complication of an infection and occurs when an extreme immune system response triggers widespread inflammation throughout the body. (1) Sepsis can be mild or severe. But regardless ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Vehicles driving westbound for the Bay Bridge from ...
In these 2025 Advanced Life Support Guidelines, the American Heart Association provides comprehensive recommendations for the resuscitation and management of adults experiencing cardiac arrest, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results